Trial intelligence / Profile preview

Luo-Fu-Shan Plaster in Rheumatoid Arthritis

NCT04884880Unknown

Sponsor
Guang'anmen Hospital
Start
May 2021
Primary completion
Dec 2021
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

Randomised, double-blind trial in rheumatoid arthritis (RA) comparing Luo-Fu-Shan Plaster with Placebo (2 arms). Primary endpoint: Visual Analogue Scale pain score at 4 weeks. Status: unknown.

02

Drugs

luo-fu-shan plaster
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT04884880.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04884880.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call